Evaluation of a Crataegus -based multiherb formula for dyslipidemia: A randomized, double-blind, placebo-controlled clinical trial

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Hu, Miao ^a   Zeng, Weiwei ^a   Tomlinson, Brian ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; GLUCOSE; HEMOGLOBIN A1C; HERBACEOUS AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MULTIHERB FORMULA; PLACEBO; SERUM ALBUMIN; UNCLASSIFIED DRUG; UREA;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ALISMA; ALISMA ORIENTALIS; ARTICLE; CHINESE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; CRATAEGUS PINNATIFIDA; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSLIPIDEMIA; FALLOPIA MULTIFLORA; FEMALE; FOLLOW UP; GANODERMA LUCIDUM; GLUCOSE BLOOD LEVEL; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLUENZA; KNEE PAIN; MALE; MIDDLE AGED; MORUS ALBA; RANDOMIZED CONTROLLED TRIAL; SHOULDER PAIN; SIDE EFFECT; STIGMA MAYDIS; STOMACH DISCOMFORT; UREA BLOOD LEVEL;

EID: 84900318591     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/365742     Document Type: Article

References (38)

1. Tachjian A., Maria V., Jahangir A., Use of herbal products and potential interactions in patients with cardiovascular diseases. Journal of the American College of Cardiology 2010 55 6 515 525 2-s2.0-75249084792 10.1016/j.jacc.2009. 07.074
2. Fasinu P. S., Bouic P. J., Rosenkranz B., An overview of the evidence and mechanisms of herb-drug interactions. Frontiers in Pharmacology 2012 3, article 69 10.3389/fphar.2012.00069
3. Yang Y. L., Chan S. W., Hu M., Walden R., Tomlinson B., Effects of some common food constituents on cardiovascular disease. ISRN Cardiology 2011 2011 16 397136 10.5402/2011/397136
4. Hasani-Ranjbar S., Nayebi N., Moradi L., Mehri A., Larijani B., Abdollahi M., The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia; a systematic review. Current Pharmaceutical Design 2010 16 26 2935 2947 2-s2.0-78649910374
5. Zhang T.-T., Jiang J.-G., Active ingredients of traditional Chinese medicine in the treatment of diabetes and diabetic complications. Expert Opinion on Investigational Drugs 2012 21 11 1625 1642 10.1517/13543784.2012.713937
6. Xie W., Zhao Y., Du L., Emerging approaches of traditional Chinese medicine formulas for the treatment of hyperlipidemia. Journal of Ethnopharmacology 2012 140 2 345 367 2-s2.0-84858002823 10.1016/j.jep.2012.01. 027
7. Chang Q., Zuo Z., Harrison F., Chow M. S. S., Hawthorn. The Journal of Clinical Pharmacology 2002 42 6 605 612 2-s2.0-0036000313 10.1177/ 00970002042006003 (Pubitemid 34547444)
8. Wu J., Peng W., Qin R., Zhou H., Crataegus pinnatifida: chemical constituents, pharmacology, and potential applications. Molecules 2014 19 2 1685 1712 10.3390/molecules19021685
9. Wang J., Xiong X., Feng B., Effect of Crataegus usage in cardiovascular disease prevention: an evidence-based approach. Evidence-Based Complementary and Alternative Medicine 2013 2013 16 149363 10.1155/2013/149363
10. Ye X.-L., Huang W.-W., Chen Z., Li X.-G., Li P., Lan P., Wang L., Gao Y., Zhao Z.-Q., Chen X., Synergetic effect and structure-activity relationship of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors from crataegus pinnatifida bge. Journal of Agricultural and Food Chemistry 2010 58 5 3132 3138 2-s2.0-77949404326 10.1021/jf903337f
11. Edwards J. E., Brown P. N., Talent N., Dickinson T. A., Shipley P. R., A review of the chemistry of the genus Crataegus. Phytochemistry 2012 79 5 26 10.1016/j.phytochem.2012.04.006
12. Min S.-W., Jung S.-H., Cho K.-H., Kim D.-H., Antihyperlipidemic effects of red ginseng, crataegii fructus and their main constituents ginsenoside Rg3 and ursolic acid in mice. Biomolecules & Therapeutics 2008 16 4 364 369 2-s2.0-68649127279 10.4062/biomolther.2008.16.4.364
13. Lin Y., Vermeer M. A., Trautwein E. A., Triterpenic acids present in hawthorn lower plasma cholesterol by inhibiting intestinal ACAT activity in hamsters. Evidence-Based Complementary and Alternative Medicine 2011 2011 9 2-s2.0-79251584307 10.1093/ecam/nep007 801272
14. Kuo D.-H., Yeh C.-H., Shieh P.-C., Cheng K.-C., Chen F.-A., Cheng J.-T., Effect of ShanZha, a Chinese herbal product, on obesity and dyslipidemia in hamsters receiving high-fat diet. Journal of Ethnopharmacology 2009 124 3 544 550 2-s2.0-67651005118 10.1016/j.jep.2009.05.005
15. Niu C.-S., Chen C.-T., Chen L.-J., Cheng K.-C., Yeh C.-H., Cheng J.-T., Decrease of blood lipids induced by Shan-Zha (fruit of Crataegus pinnatifida) is mainly related to an increase of PPAR α in liver of mice fed high-fat diet. Hormone and Metabolic Research 2011 43 9 625 630 2-s2.0-80051800721 10.1055/s-0031-1283147
16. Bahorun T., Trotin F., Pommery J., Vasseur J., Pinkas M., Antioxidant activities of Crataegus monogyna extracts. Planta Medica 1994 60 4 323 328 2-s2.0-0027980773 10.1055/s-2006-959493 (Pubitemid 24255925)
17. 2 biosynthesis in vitro by the main components of Crataegus oxyacantha (Hawthorn) flower heads. Prostaglandins Leukotrienes and Essential Fatty Acids 1994 50 4 173 175 2-s2.0-0028176551 10.1016/0952-3278(94)90141-4
18. Zand J., Lanza F., Garg H. K., Bryan N. S., All-natural nitrite and nitrate containing dietary supplement promotes nitric oxide production and reduces triglycerides in humans. Nutrition Research 2011 31 4 262 269 2-s2.0-79955375799 10.1016/j.nutres.2011.03.008
19. Zhang Z., Ho W. K., Huang Y., Anthony E. J., Lam L. W., Chen Z.-Y., Hawthorn fruit is hypolipidemic in rabbits fed a high cholesterol diet. The Journal of Nutrition 2002 132 1 5 10 2-s2.0-0036140196 (Pubitemid 34042447)
20. Xu H., Xu H.-E., Ryan D., A study of the comparative effects of Hawthorn fruit compound and Simvastatin on lowering blood lipid levels. American Journal of Chinese Medicine 2009 37 5 903 908 2-s2.0-74049153853 10.1142/ S0192415X09007302
21. Wang T., An Y., Zhao C., Han L., Boakye-Yiadom M., Wang W., Zhang Y., Regulation effects of Crataegus pinnatifida leaf on glucose and lipids metabolism. Journal of Agricultural and Food Chemistry 2011 59 9 4987 4994 2-s2.0-79955686550 10.1021/jf1049062
22. Chen J. D., Wu Y. Z., Tao Z. L., Chen Z. M., Liu X. P., Hawthorn (shan zha) drink and its lowering effect on blood lipid levels in humans and rats. World Review of Nutrition and Dietetics 1995 77 147 154 2-s2.0-0029192908
23. Liu Q.-L., Xiao J.-H., Ma R., Ban Y., Wang J.-L., Effect of 2,3,5,4′-tetrahydroxystilbene-2-O-beta-d-glucoside on lipoprotein oxidation and proliferation of coronary arterial smooth cells. Journal of Asian Natural Products Research 2007 9 8 689 697 2-s2.0-36248964199 10.1080/17415990500209064
24. Lin H.-R., Triterpenes from Alisma orientalis act as farnesoid X receptor agonists. Bioorganic & Medicinal Chemistry Letters 2012 22 14 4787 4792
25. Hong X., Tang H., Wu L., Li A., Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease. Journal of Pharmacy and Pharmacology 2006 58 10 1391 1398 2-s2.0-33750067702 10.1211/jpp.57.10.0013 (Pubitemid 44580570)
26. Wang H. J., Chiang B. H., Anti-diabetic effect of a traditional Chinese medicine formula. Food & Function 2012 3 11 1161 1169
27. Sanodiya B. S., Thakur G. S., Baghel R. K., Prasad G. B. K. S., Bisen P. S., Ganoderma lucidum: a potent pharmacological macrofungus. Current Pharmaceutical Biotechnology 2009 10 8 717 742 2-s2.0-73649107884 10.2174/138920109789978757
28. Hasanudin K., Hashim P., Mustafa S., Corn silk (Stigma maydis) in healthcare: a phytochemical and pharmacological review. Molecules 2012 17 8 9697 9715 10.3390/molecules17089697
29. Seto S. W., Lam T. Y., Tam H. L., Au A. L. S., Chan S. W., Wu J. H., Yu P. H. F., Leung G. P. H., Ngai S. M., Yeung J. H. K., Leung P. S., Lee S. M. Y., Kwan Y. W., Novel hypoglycemic effects of Ganoderma lucidum water-extract in obese/diabetic (+ db /+ db) mice. Phytomedicine 2009 16 5 426 436 2-s2.0-64649089598 10.1016/j.phymed.2008.10.004
30. Chu T. T., Benzie I. F., Lam C. W., Fok B. S., Lee K. K., Tomlinson B., Study of potential cardioprotective effects of Ganoderma lucidum (Lingzhi): results of a controlled human intervention trial. British Journal of Nutrition 2012 107 7 1017 1027 10.1017/S0007114511003795
31. Wachtel-Galor S., Tomlinson B., Benzie I. F. F., Ganoderma lucidum ("Lingzhi"), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. British Journal of Nutrition 2004 91 2 263 269 2-s2.0-1342282406 10.1079/BJN20041039 (Pubitemid 38263543)
32. Kaup S. R., Arunkumar N., Bernhardt L. K., Vasavi R. G., Shetty S. S., Pai S. R., Arunkumar B., Antihyperlipedemic activity of Cynodon dactylon extract in high-cholesterol diet fed Wistar rats. Genomic Medicine, Biomarkers, and Health Sciences 2011 3 3 98 102 2-s2.0-84860265082 10.1016/j.gmbhs.2011.11.001
33. Kobayashi Y., Miyazawa M., Kamei A., Abe K., Kojima T., Ameliorative effects of mulberry (Morus alba L.) leaves on hyperlipidemia in rats fed a high-fat diet: induction of fatty acid oxidation, inhibition of lipogenesis, and suppression of oxidative stress. Bioscience, Biotechnology and Biochemistry 2010 74 12 2385 2395 2-s2.0-78650665645 10.1271/bbb.100392
34. Lee Y. J., Choi D. H., Kim E. J., Kim H. Y., Kwon T. O., Kang D. G., Lee H. S., Hypotensive, hypolipidemic, and vascular protective effects of Morus alba L. in rats fed an atherogenic diet. The American Journal of Chinese Medicine 2011 39 1 39 52 2-s2.0-78751549143 10.1142/S0192415X11008634
35. Liu L. I.-K., Chou F.-P. I., Chen Y. I.-C., Chyau C.-C., Ho H.-H., Wang C.-J., Effects of mulberry (Morus alba L.) extracts on lipid homeostasis in vitro and in vivo. Journal of Agricultural and Food Chemistry 2009 57 16 7605 7611 2-s2.0-70349194909 10.1021/jf9014697
36. Dalli E., Colomer E., Tormos M. C., Crataegus laevigata decreases neutrophil elastase and has hypolipidemic effect: a randomized, double-blind, placebo-controlled trial. Phytomedicine 2011 18 8-9 769 775 2-s2.0-79958092564 10.1016/j.phymed.2010.11.011
37. Friedewald W. T., Levy R. I., Fredrickson D. S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 6 499 502 2-s2.0-0015348189
38. Sun S., Xu H., Ngeh L., The evaluation of Chinese therapeutic food for the treatment of moderate dyslipidemia. Evidence-Based Complementary and Alternative Medicine 2012 2012 10 2-s2.0-84859753085 10.1155/2012/508683 508683